Sick Reaches Forecast Targets For 2019

病态在充满挑战的市场环境中继续增长。在2019财政年度（2018年：16.6368亿欧元）期间，传感器生产商的集体销售增长了7％，达到1,75070万欧元。因此，增长远高于传感器行业的平均值，AMA传感器和测量协会估计2019年为-1％。患病再次获得了高水平的订单，2019年（2018年：1,701.1万欧元）的命中率达到17.741亿欧元。全球员工人数增长了2.6％，达到10,204。除了提高效率的措施外，销售增长还增加了EBIT增长13.1％，至1.329亿欧元，这是总销售额的7.6％的比例。，保持高水平。因此，尽管该公司面临全球经济的低迷，全球贸易冲突的加深以及工厂自动化尤其是汽车部门的艰难市场状况，但病人可能会达到2019财年的预测目标。然而，病情继续遵循其创新策略，并再次投入了大部分销售额，11.5％在研发上。“许多行业都面临着根本性的结构变化和日益动态的数字化。Sick遵守其在研发上的高度投资，以便继续推动新技术与我们的传统自动化业务一起推动新技术。这是我们和我们的客户可以利用数字技术机会使我们能够对迅速变化的经济状况做出反应的唯一途径。。 Most of the Start-Up Initiatives founded in 2018 have already reached market maturity and contributed to sales with their solutions, for example Artificial Intelligence-supported camera sensors or systems for automated guided vehicles in intralogistics.

传感器和应用系统需求的主要市场差异
在个人业务部门和地区收到的订单和销售是高度异质的，反映了动态的经济发展。尽管全球需求在工厂自动化中均下降，但Sick能够在物流自动化和流程自动化方面获得市场份额。这种广泛的定位使公司能够弥补各个细分市场的停滞。除了在既定市场中的存在外，世界增长地区的销售活动还有助于进一步的销售。德国国内市场的销售额略低于2018年，下降了0.6％。德国公司不愿进行投资是造成销售损失的原因，尤其是在汽车行业。在欧洲，中东和非洲（EMEA）的销售地区，财政年度更加稳定。尽管经济放缓，但病人在这里的销售额增长了7.9％，尤其是在意大利，奥地利，瑞典和挪威以及英国的业务，这取决于积极的动力。北美洲，中美洲（美洲）的销售增长7.6％。Sick能够利用内部和运输物流以及石油和天然气行业的进一步需求。 The strongest growth region worldwide remained the Asia-Pacific region, where development was dynamic. With growth of 11.3%, Sick achieved a double-digit increase in sales again in 2019, with business volumes rising in China and Japan in particular. Currency effects had a slightly positive influence on the development of corporate sales during the 2019 fiscal year.

高盈利能力为动荡时代提供了稳定的基础
利息和税收之前的收入（EBIT）从2019年营业年中的1.175亿欧元增加到1.329亿欧元。通过放松采购市场以及随后的非凡支出以确保交付能力的情况下，这一发展得到了支持。随着销售的令人满意的增长，病假在2019年再次获得了高利润。病假集团的高利润能够保护确保其市场地位和创新领导所必需的未来投资。此外，它在当前的冠状病毒大流行期间为公司的稳定提供了稳定，这将对2020财政年度产生不可预见的经济影响。

创业和现有业务的创新创新
As has been the case in recent years, Sick made major investments in research and development during the 2019 fiscal year. The company spent a total of EUR 202.0 million—11.5% of sales—on R&D activities (2018: EUR 192.5 million). Sick has expanded its product portfolio for existing business in order to ensure that it is even better prepared for fluctuations in individual markets with greater diversification of its range. Product development focused on the networking capability of sensors in the context of Industry 4.0, as well as data sovereignty. Sick sensors are increasingly developing towards sensor intelligence with the integration of application knowledge in the software of individual products, and the possibilities offered by more powerful processors and data storage technologies. The Start-Up Initiatives were also highly dynamic, and were able to acquire customer projects and achieve sales. An application involving camera sensors in a neuronal network, for example, was continuously trained by means of deep learning algorithms and could thus be used for package recognition in logistics.

病现在在全球拥有10,000多名员工
Accompanying the growth in sales, the number of employees also increased slightly, by 2.6%, during the 2019 fiscal year. 10,204 employees are now active at Sick sites worldwide, of which 1,310 are involved in research and development. Human resources work was largely characterized by the continued buildup of competences to meet the challenges posed by the digital transformation, the need for agility, and increasing complexity. Sick’s continuously high expenditure on training and further education is designed to open up for its employees the opportunities offered by the digital transformation in a highly innovative environment.

High levels of orders received during the first quarter of 2020 – forecasting uncertain due to the coronavirus pandemic
在Covid-19-19，整体经济状况已经具有挑战性。在2020年的最初几个月中，病人能够继续达到令人满意的销售水平和收到的订单。该公司观察到了冠状病毒大流行的开始以及许多国家的关闭，并迅速采取了措施，以保护其员工，公司本身并保持交付能力。在全球范围内减缓这种病毒感染的传播是世界社区从未面临过的挑战。目前无法估计经济影响。但是，已经可以看出，2020年的命令和业务发展将受到医疗和经济危机的损害。但是对自动化系统的需求，例如在物流中，即使在当前情况下，也仍然很高。病人可以继续使用其创新的产品和服务组合来支持公司克服危机后业务流程的限制。凭借其坚实的财务基础，病态团体有希望掌握这个具有挑战性的阶段。